PUBLISHED DATE : Jan 2023 | Pages : 243
Fill out your details & get your free sample
The U.S. Clinical Nutrition Market Size, Share, and Growth Forecast by:
Industry Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share, & Forecast 2022-2027
243 Pages
56 Tables
143 Charts
1 Regions
1 Countries
25 Companies
6 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2027) | USD 16.63 Billion |
| Market Size (2021) | USD 12.07 Billion |
| CAGR (2021-2027) | 5.49% |
| Base Year | 2021 |
| Forecast Year | 2022-2027 |
| Market Segments | Products, Route of Administration, Age Group, Application, Distribution Channels, and End-Users |
| KEY VENDORS | Abbott, B. Braun Melsungen Ag., Baxter, Danone, Fresenius Kabi, Nestle, Perrigo Company, and Reckitt Benckiser Group |
The U.S. clinical nutrition market is expected to grow at a CAGR of 5.49% from 2021 to 2027 and is expected to reach USD 16.63 billion by 2027 from USD 12.07 billion in 2021. The innovation in personalized and targeted clinical nutrition solutions delivers new industry growth opportunities in the U.S. clinical nutrition market. The personalization and targeted solution approach stand with specific formulations that fulfill the need for nutritional support for patients suffering from chronic diseases and associated illnesses. In addition, the COVID-19 pandemic positively influenced the innovation in targeted and personalized clinical nutrition solutions. On another side, the increasing birth rate and the rising demand for milk-based nutritional support products by infants and toddler gives new aspects for vendors in the U.S. clinical nutrition market.
Clinical nutrition, known as medical nutrition, is the practice of analyzing and identifying whether an individual is consuming an adequate amount of nutrients for health. It can also be defined as the study of an overall analysis relationship between ingested meals and the well-being of a person's body. Clinical nutrition prioritizes the management of nutritional adjustment and helps diagnose and prevent nutritional level changes in the human body suffering from chronic conditions.
The U.S. government implements a tremendous breadth and depth of initiatives relevant to the country's nutrition level. So, the increasing government initiatives to improve the country's nutritional health and the rising concern about food insecurity across US families are expected to drive significant U.S. clinical nutrition market growth. In addition, the increasing geriatric population and chronic disease prevalence are constantly fueling industry growth. Obesity, hypertension, gastrointestinal disorders, CVD, and other primary health conditions primely accelerate the country's malnutrition rate, creating a high demand for clinical nutrition. However, there are some limitations to the industry growth, like potential side-effects associated with clinical nutrition and challenges in enteral nutrition deliveries, pediatric ICU patients, and more, hampering the industry growth.
Increasing Demand for the Personalized and Targeted Clinical Nutrition
Personalized clinical nutrition is one of the trending approaches in clinical nutrition to fulfill the nutritional demand of every individual patient suffering from specific conditions. The targeted nutrition innovations deliver promising opportunities in medical practices and consumer and food production companies. Innovation in targeted and personalized solutions continues to grow and evolve rapidly in recent years with the increasing consumer demand from food systems to support their health and well-being. In addition, there is an increase in the number of digital tools in the research phase to calculate the nutrition requirement, scan the food based on appearance and help the individuals monitor their nutrition intake. This will further revolutionize the U.S. clinical nutrition market in the future.
Increasing Demand For The Infant Nutrition
One of the significant concerns in infants and toddlers arising rapidly in the US is the low-weight birth rate. About one in 12 babies is born with a low birth rate in the US. Increasing infant birth rates with lower weight delivers significant industry growth opportunities in milk-based nutritional products for U.S. clinical nutrition market players. Milk-based nutritional products are not new in the industry, but increasing demand and high competition among the industry players resulted in innovative product deliveries in recent years.
In 2021, the North American Based Organization Nutricia (by Danone) got approval for the new infant nutrition product Fortini from US FDA. This product is developed to support children living with the risk of growth deficiencies and those with increased energy requirements.
INSIGHTS BY ROUTE OF ADMINISTRATION
The U.S. clinical nutrition market by route of administration is segmented into oral, enteral, and parenteral, of which the oral segment dominated the industry with a higher share in 2021; due to the higher preference. At homecare, the oral route of administering clinical nutrition solutions is highly preferred among the pediatric population. The oral route of administration accounted for a higher 45.51% industry share.
In 2021, the enteral segment showed dominance over the parenteral segment, with a 36.36% share in the U.S. clinical nutrition market. Enteral nutrition is one of the vital parts of nutrition therapy when the patient cannot meet the nutritional demand by oral intervention. Enteral nutrition is commonly delivered from pediatric to geriatric populations when the patient suffers from gastrointestinal disease.
INSIGHTS BY PRODUCT
The U.S. clinical nutrition market is segmented into powder, liquid, and semi-solid under the products segment. In 2021, the powder product segment accounted for approx. 52% of the U.S. clinical nutrition market share. The high adoption, new product innovation, and higher recommendation by professionals drive significant segmental growth and dominate the other two segments with higher industry share.
The liquid segment in the U.S. clinical nutrition market was valued at USD 3.08 billion in 2021. Liquid form clinical nutrition products deliver enteral and parenteral nutrition therapy. Ready-to-drink is a significant category in the liquid form clinical nutrition product category and is trending in the industry. Their increasing energy drink use in sports and physical activities and rapid energy boosting accelerate high segmental growth.
INSIGHTS BY AGE GROUP
By age group, the infant and toddlers segment shows lucrative opportunities and is growing at a CAGR of 6.61% during the forecast period. The infant and toddler population is a rapidly growing segment in the U.S. clinical nutrition market. Further, the child and teenage segment accounted for a 30.83% industry share and dominated the other segments.
Opportunities for Industry Growth in the US by Child & Teenage 2021
INSIGHTS BY APPLICATION
Malnutrition is one of the major concerns addressed in the US population. Due to the increasing prevalence of various chronic conditions such as obesity/overweight, diabetes, hypertension, GI disorders, CVD, and others led to malnutrition in hospitalized as well as the general population and demand for clinical nutrition. In 2021, the malnutrition segment accounted for a 42.01% higher U.S. clinical nutrition market share and dominated other segments. Currently, more than 40 million US people and around 12 million children are food insure. Many US-based families face poverty and hunger challenges in areas where unprocessed and fresh healthy food is unavailable or sometimes expensive.
Cancer patients are likely to lose weight due to less eating due to stress, pain, diagnosis and treatments, nausea, and test change. Cancer-related malnutrition affects one out of three cancer patients. The U.S. clinical nutrition market by cancer is growing at a CAGR of 6.96% during the forecast period. The demand for good nutrition is significant if the person has cancer due to its illness, and treatments can impact food consumption. Also, cancer treatments impact how the body tolerates certain foods and uses nutrients. If that severe condition appears in the patients, professionals recommend clinical nutrition to the patients and deliver care.
INSIGHTS BY DISTRIBUTION CHANNEL
The U.S. clinical nutrition market by distribution channels is segmented into institutional sales channels, supermarkets and hypermarkets, pharmacies and drug stores, specialty stores, and online sales channels. In 2021, the institutional sales segment accounted for 45.53% industry share in the clinical nutrition market in the US. Institutional sales channels are emerging distribution channels for the clinical nutrition industry, which differ entirely from healthcare practitioner distribution channels. Some industry players came up with unique distribution channels to eliminate the delay and third-party interference in the supply of products.
The supermarket & hypermarket U.S. clinical nutrition market was valued at USD 2.07 billion in 2021. For clinical nutrition, supermarkets and hypermarket are large retail stores operated by self-services that offer milk-based formulas, energy drinks, ready-to-drink, and other clinical nutrition and dietary products recommended by professionals. On the other side, the hypermarket plays a vital role in clinical nutrition products sale. It is one-stop shopping where most of the required clinical nutrition products are available in large amounts, so small retailers or customers can buy them and drive the sale.
INSIGHTS BY END-USER
With the increasing prevalence of malnutrition, metabolic disorders, cancer, GI disorders, and other medical conditions, the hospitalization rate also increased in the US. Hospitals play a vital role in oral, enteral, and parenteral clinical nutrition therapies and contribute to higher industry growth under the end-user segment. In 2021, hospital segments accounted for a 41.95% U.S. clinical nutrition market share. The increasing number of hospital stays led to a rising rate of malnutrition. In the US, millions of people have hospital stays annually and account for malnutrition care which significantly drives the adoption of clinical nutrition therapies in hospitals. The significant demand for oral nutrition supplements (ONS), specifically developed for energy, protein, and other nutrient delivery propels the significant segmental growth.
Homecare is one of the trending healthcare settings widely accepted in the US. After the emergence of the COVID-19 pandemic, most ICU patients and hospitalized patients prefer home nutrition therapies due to their benefits and keep matter with their comfort. Home care nutrition therapies give patients the best environment, showing the rapid recovery of chronically ill patients—the availability of home enteral and parenteral clinical nutrition therapy providers in the US fuel the industry's growth. The homecare U.S. clinical nutrition market is growing at a CAGR of 5.86% during the forecast period.
Abbott, B. Braun Melsungen Ag, Baxter, Danone, Fresenius Kabi, Nestle, Perrigo Company, and Reckitt Benckiser Group are the leading players in the U.S. clinical nutrition market players, accounting for the higher industry share in the United States. On the other hand, emerging players and new start-ups are trying to achieve a solid customer base and market expansion. The presence of emerging industry players positively influences the competition in the clinical nutrition market in the US. The primary competition among the industry players accounted due to new product launches, emerging, and gold standard formulations.
Competition Among the Major Industry Players
Frequently Asked Questions
What is the size of the U.S. clinical nutrition market?
The U.S. clinical nutrition market size was valued at USD 12.07 billion in 2021 and is expected to reach USD 16.63 billion by 2027. The innovation in personalized and targeted clinical nutrition solutions delivers new growth opportunities in the U.S. clinical nutrition market.
What is the projected growth rate of the U.S. clinical nutrition market?
The U.S. clinical nutrition market share is expected to grow at a CAGR of 5.49% from 2022 to 2027.
What are the trends in the U.S. clinical nutrition market?
Innovation in Personalization and Targeted Solutions, Increasing Demand for Infant Nutrition, Advancement in Nutritional Therapies, and Shift Towards Home Nutritional Care are the significant trends in the U.S. clinical nutrition market.
Who are the key players in the U.S. clinical nutrition market?
Abbott, B. Braun Melsungen Ag., Baxter, Danone, Fresenius Kabi, Nestle, Perrigo Company, and Reckitt Benckiser Group are the leading U.S. clinical nutrition market companies.
Which product segment is expected to dominate the U.S. clinical nutrition market?
The powder segment accounted for 51.99% U.S. clinical nutrition market share and dominated the product segment.
The U.S. clinical nutrition market is expected to grow at a CAGR of approximately 5.49% from 2021 to 2027.
The following factors are likely to contribute to the growth of the U.S. clinical nutrition market during the forecast period:
Base Year: 2021
Forecast Year: 2022-2027
The report considers the present scenario of the U.S. clinical nutrition market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the market.
Key Vendors
Other Prominent Vendors
Segmentation by Products
Segmentation by Route of Administration
Segmentation by Age Group
Segmentation by Application
Segmentation by Distribution Channels
Segmentation by End-Users
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY PRODUCTS
4.3.2 MARKET SEGMENTATION BY ROUTE OF ADMINISTRATION
4.3.3 MARKET SEGMENTATION BY AGE GROUP
4.3.4 MARKET SEGMENTATION BY APPLICATION
4.3.5 MARKET SEGMENTATION BY DISTRIBUTION CHANNELS
4.3.6 MARKET SEGMENTATION BY END-USERS
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
8 PREMIUM INSIGHTS
9 MARKET OPPORTUNITIES & TRENDS
9.1 INNOVATION IN PERSONALIZATION AND TARGETED SOLUTIONS
9.2 INCREASING DEMAND FOR INFANT NUTRITION
9.3 ADVANCES IN NUTRITIONAL THERAPIES
9.4 SHIFT TOWARD HOME NUTRITIONAL CARE
10 MARKET GROWTH ENABLERS
10.1 GOVERNMENT INITIATIVES, INVESTMENTS, AND FUNDING FOR CLINICAL NUTRITION RESEARCH
10.2 INCREASING CHRONIC DISEASE PREVALENCE REQUIRES NUTRITIONAL SUPPORT
10.3 IMPACT OF COVID-19 ON CLINICAL NUTRITION
11 MARKET RESTRAINTS
11.1 SIDE EFFECTS AND COMPLICATIONS DUE TO CLINICAL NUTRITION
11.2 BARRIERS TO DELIVERING ENTERAL NUTRITION IN PEDIATRIC ICU
11.3 HIGH COST OF CLINICAL NUTRITION
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.1.1 CLINICAL NUTRITION MARKET IN US: PRODUCT SEGMENTATION INSIGHTS
12.1.2 CLINICAL NUTRITION MARKET IN US: PRODUCT SEGMENTATION INSIGHTS
12.1.3 CLINICAL NUTRITION MARKET IN US BY APPLICATION
12.1.4 CLINICAL NUTRITION MARKET IN US BY AGE GROUP
12.1.5 CLINICAL NUTRITION MARKET IN US BY DISTRIBUTION CHANNEL
12.1.6 CLINICAL NUTRITION MARKET IN US BY END-USER
12.2 MARKET SIZE & FORECAST
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 ROUTE OF ADMINISTRATION
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 ORAL
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 ORAL PRODUCT MARKET BY ROUTE OF ADMINISTRATION
13.4 ENTERAL
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 ENTERAL PRODUCT MARKET BY AGE GROUP
13.5 PARENTERAL
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 PARENTERAL PRODUCT MARKET BY AGE GROUP
14 PRODUCT
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 POWDER
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.4 LIQUID
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.5 SEMI-SOLID
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
15 AGE GROUP
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 CHILD AND TEENAGER
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.4 ADULT
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.5 INFANT & TODDLER
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.6 GERIATRIC
15.6.1 MARKET OVERVIEW
15.6.2 MARKET SIZE & FORECAST
16 APPLICATION
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 MALNUTRITION
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.4 METABOLIC DISORDERS
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.5 GASTROINTESTINAL DISEASES
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.6 CANCER
16.6.1 MARKET OVERVIEW
16.6.2 MARKET SIZE & FORECAST
16.7 OTHERS
16.7.1 MARKET OVERVIEW
16.7.2 MARKET SIZE & FORECAST
17 DISTRIBUTION CHANNEL
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 MARKET OVERVIEW
17.3 INSTITUTIONAL SALES
17.3.1 MARKET OVERVIEW
17.3.2 MARKET SIZE & FORECAST
17.4 SUPERMARKET & HYPERMARKET
17.4.1 MARKET OVERVIEW
17.4.2 MARKET SIZE & FORECAST
17.5 ONLINE CHANNELS
17.5.1 MARKET OVERVIEW
17.5.2 MARKET SIZE & FORECAST
17.6 PHARMACIES & DRUG STORES
17.6.1 MARKET OVERVIEW
17.6.2 MARKET SIZE & FORECAST
17.7 SPECIALTY STORES
17.7.1 MARKET OVERVIEW
17.7.2 MARKET SIZE & FORECAST
17.8 OTHERS
17.8.1 MARKET OVERVIEW
17.8.2 MARKET SIZE & FORECAST
18 END-USER
18.1 MARKET SNAPSHOT & GROWTH ENGINE
18.2 MARKET OVERVIEW
18.3 HOSPITALS
18.3.1 MARKET OVERVIEW
18.3.2 MARKET SIZE & FORECAST
18.4 INDIVIDUAL
18.4.1 MARKET OVERVIEW
18.4.2 MARKET SIZE & FORECAST
18.5 HOMECARE
18.5.1 MARKET OVERVIEW
18.5.2 MARKET SIZE & FORECAST
18.6 LONG-TERM CARE CENTERS
18.6.1 MARKET OVERVIEW
18.6.2 MARKET SIZE & FORECAST
19 COMPETITIVE LANDSCAPE
19.1 COMPETITION OVERVIEW
19.2 MARKET SHARE ANALYSIS
19.2.1 ABBOTT
19.2.2 B. BRAUN MELSUNGEN AG
19.2.3 BAXTER
19.2.4 DANONE
19.2.5 FRESENIUS KABI
19.2.6 NESTLE
19.2.7 PERRIGO COMPANY
19.2.8 RECKITT BENCKISER
20 KEY COMPANY PROFILES
20.1 ABBOTT
20.1.1 BUSINESS OVERVIEW
20.1.2 PRODUCT OFFERINGS
20.1.3 KEY STRATEGIES
20.1.4 KEY STRENGTHS
20.1.5 KEY OPPORTUNITIES
20.2 B. BRAUN MELSUNGEN AG
20.2.1 BUSINESS OVERVIEW
20.2.2 PRODUCT OFFERINGS
20.2.3 KEY STRATEGIES
20.2.4 KEY STRENGTHS
20.2.5 KEY OPPORTUNITIES
20.3 BAXTER
20.3.1 BUSINESS OVERVIEW
20.3.2 PRODUCT OFFERINGS
20.3.3 KEY STRATEGIES
20.3.4 KEY STRENGTHS
20.3.5 KEY OPPORTUNITIES
20.4 DANONE
20.4.1 BUSINESS OVERVIEW
20.4.2 PRODUCT OFFERINGS
20.4.3 KEY STRATEGIES
20.4.4 KEY STRENGTHS
20.4.5 KEY OPPORTUNITIES
20.5 FRESENIUS KABI
20.5.1 BUSINESS OVERVIEW
20.5.2 PRODUCT OFFERINGS
20.5.3 KEY STRATEGIES
20.5.4 KEY STRENGTHS
20.5.5 KEY OPPORTUNITIES
20.6 NESTLE
20.6.1 BUSINESS OVERVIEW
20.6.2 PRODUCT OFFERINGS
20.6.3 KEY STRATEGIES
20.6.4 KEY STRENGTHS
20.6.5 KEY OPPORTUNITIES
20.7 PERRIGO COMPANY
20.7.1 BUSINESS OVERVIEW
20.7.2 PRODUCT OFFERINGS
20.7.3 KEY STRATEGIES
20.7.4 KEY STRENGTHS
20.7.5 KEY OPPORTUNITIES
20.8 RECKITT BENCKISER GROUP
20.8.1 BUSINESS OVERVIEW
20.8.2 PRODUCT OFFERINGS
20.8.3 KEY STRATEGIES
20.8.4 KEY STRENGTHS
20.8.5 KEY OPPORTUNITIES
21 OTHER PROMINENT VENDORS
21.1 ADM
21.1.1 BUSINESS OVERVIEW
21.1.2 PRODUCT OFFERINGS
21.2 AJINOMOTO CO
21.2.1 BUSINESS OVERVIEW
21.2.2 PRODUCT OFFERINGS
21.3 BASF SE
21.3.1 BUSINESS OVERVIEW
21.3.2 PRODUCT OFFERINGS
21.4 DSM
21.4.1 BUSINESS OVERVIEW
21.4.2 PRODUCT OFFERINGS
21.5 ENVARA HEALTH
21.5.1 BUSINESS OVERVIEW
21.5.2 PRODUCT OFFERINGS
21.6 GLANBIA PLC
21.6.1 BUSINESS OVERVIEW
21.6.2 PRODUCT OFFERINGS
21.7 HERO NUTRITIONALS
21.7.1 BUSINESS OVERVIEW
21.7.2 PRODUCT OFFERINGS
21.8 HUM NUTRITION
21.8.1 BUSINESS OVERVIEW
21.8.2 PRODUCT OFFERINGS
21.9 KENDAL NUTRICARE
21.9.1 BUSINESS OVERVIEW
21.9.2 PRODUCT OFFERINGS
21.10 LONZA
21.10.1 BUSINESS OVERVIEW
21.10.2 PRODUCT OFFERINGS
21.11 LACTALIS NUTRITION SANTÉ
21.11.1 BUSINESS OVERVIEW
21.11.2 PRODUCT OFFERINGS
21.12 MEND
21.12.1 BUSINESS OVERVIEW
21.12.2 PRODUCT OFFERINGS
21.13 MEDIFOOD INTERNATIONAL SA
21.13.1 BUSINESS OVERVIEW
21.13.2 PRODUCT OFFERINGS
21.14 PRIMUS PHARMACEUTICALS
21.14.1 BUSINESS OVERVIEW
21.14.2 PRODUCT OFFERINGS
21.15 STERNLIFE GMBH & CO. KG
21.15.1 BUSINESS OVERVIEW
21.15.2 PRODUCT OFFERINGS
21.16 THE CRAFT HEAINZ COMPANY
21.16.1 BUSINESS OVERVIEW
21.16.2 PRODUCT OFFERINGS
21.17 VIVANTE HEALTH
21.17.1 BUSINESS OVERVIEW
21.17.2 PRODUCT OFFERINGS
22 REPORT SUMMARY
22.1 KEY TAKEAWAYS
22.2 STRATEGIC RECOMMENDATIONS
23 QUANTITATIVE SUMMARY
23.1 MARKET BY PRODUCT
23.2 MARKET BY ROUTE OF ADMINISTRATION
23.3 MARKET BY AGE GROUP
23.4 MARKET BY APPLICATION
23.5 MARKET BY DISTRIBUTION CHANNEL
23.6 MARKET BY END-USERS
23.7 ROUTE OF ADMINISTRATION MARKET BY AGE GROUP
23.7.1 ORAL CLINICAL NUTRITION MARKET IN US BY AGE GROUP
23.7.2 ENTERAL CLINICAL NUTRITION MARKET IN US BY AGE GROUP
23.7.3 PARENTERAL CLINICAL NUTRITION MARKET IN US BY AGE GROUP
24 APPENDIX
24.1 ABBREVIATIONS
EXHIBIT 1 SEGMENTATION OF CLINICAL NUTRITION MARKET IN US
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 US HEALTH CONDITIONS AND STATISTICS 2020
EXHIBIT 4 CLINICAL NUTRITION MARKET IN US: TRENDS & DRIVERS
EXHIBIT 5 CLINICAL NUTRITION MARKET IN US: SEGMENTATION
EXHIBIT 6 IMPACT OF INNOVATION IN PERSONALIZATION AND TARGETED SOLUTIONS
EXHIBIT 7 TARGETED NUTRITION TYPES AND BENEFITS
EXHIBIT 8 INCREASING DEMAND FOR INFANT NUTRITION
EXHIBIT 9 PREVALENCE OF INFANTS WITH LOW BIRTH WEIGHT 200-2022 (%)
EXHIBIT 10 PERCENTAGE OF BABIES BORN LOW BIRTHWEIGHT BY STATES IN US (2020)
EXHIBIT 11 BIRTHWEIGHT & GESTATION STATISTICS IN US (2020)
EXHIBIT 12 IMPACT OF ADVANCES IN NUTRITIONAL THERAPIES
EXHIBIT 13 NOVEL FORMULATION: TRANSFORMATIVE INNOVATIONS
EXHIBIT 14 IMPACT OF SHIFT TOWARD HOME NUTRITIONAL CARE
EXHIBIT 15 HOME NUTRITION DRIVING FACTOR BY PARENTERAL & ENTERAL NUTRITION
EXHIBIT 16 IMPACT OF GOVERNMENT INITIATIVES INVESTMENTS AND FUNDING FOR CLINICAL NUTRITION RESEARCH
EXHIBIT 17 US GOVERNMENT DEPARTMENTS & AGENCIES ENGAGED IN COUNTRIES NUTRITION ENHANCEMENT
EXHIBIT 18 CONGRESSIONAL NUTRITION FUNDING COMPARED TO NUMBER OF CHILDREN STUNTED 2010-2019
EXHIBIT 19 IMPACT OF INCREASING CHRONIC DISEASES PREVALENCE REQUIRES NUTRITIONAL SUPPORT
EXHIBIT 20 US HOUSEHOLDS BY FOOD SECURITY STATUS 2020 (%)
EXHIBIT 21 US PREVALENCE OF STUNTING WASTING AND OVERWEIGHT CONDITIONS AMONG CHILDREN (5 YEARS OF AGE) (2000-2018)
EXHIBIT 22 IMPACT OF COVID-19 ON CLINICAL NUTRITION
EXHIBIT 23 IMPACT OF SIDE EFFECTS AND COMPLICATIONS DUE TO CLINICAL NUTRITION
EXHIBIT 24 DRAWBACKS OF CLINICAL NUTRITION
EXHIBIT 25 IMPACT OF BARRIERS TO DELIVERING ENTERAL NUTRITION IN PEDIATRIC ICU
EXHIBIT 26 IMPACT OF HIGH COST OF CLINICAL NUTRITION
EXHIBIT 27 CLINICAL NUTRITION MARKET IN US: MARKET SEGMENTATION
EXHIBIT 28 CLINICAL NUTRITION MARKET IN US BY PRODUCT
EXHIBIT 29 CLINICAL NUTRITION MARKET IN US BY PRODUCT
EXHIBIT 30 CLINICAL NUTRITION MARKET IN US BY APPLICATION
EXHIBIT 31 CLINICAL NUTRITION MARKET IN US BY AGE GROUP
EXHIBIT 32 CLINICAL NUTRITION MARKET IN US BY DISTRIBUTION CHANNEL
EXHIBIT 33 CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 34 FIVE FORCES ANALYSIS 2021
EXHIBIT 35 INCREMENTAL GROWTH BY ROUTE OF ADMINISTRATION 2021 & 2027
EXHIBIT 36 CLINICAL NUTRITION MARKET IN US BY ROUTE OF ADMINISTRATION 2021-2027
EXHIBIT 37 CLINICAL NUTRITION MARKET IN US BY ROUTE OF ADMINISTRATION: OVERVIEW
EXHIBIT 38 CLINICAL NUTRITION MARKET IN US BY ROUTE OF ADMINISTRATION: INCREMENTAL GROWTH
EXHIBIT 39 CLINICAL NUTRITION MARKET IN US BY ROUTE OF ADMINISTRATION: ABSOLUTE GROWTH
EXHIBIT 40 ORAL CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 41 ORAL CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 42 ENTERAL CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 43 ENTERAL CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 44 PARENTERAL CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 45 PARENTERAL CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 46 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 47 CLINICAL NUTRITION MARKET IN US BY PRODUCT 2021-2027
EXHIBIT 48 CLINICAL NUTRITION MARKET IN US BY PRODUCT: OVERVIEW
EXHIBIT 49 CLINICAL NUTRITION MARKET IN US BY PRODUCT: INCREMENTAL GROWTH
EXHIBIT 50 CLINICAL NUTRITION MARKET IN US BY PRODUCT: ABSOLUTE GROWTH
EXHIBIT 51 POWDER CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 52 POWDER CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 53 LIQUID CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 54 LIQUID CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 55 SEMI-SOLID ORAL NUTRITIONAL SUPPLEMENTS FOR VARIOUS CLINICAL INDICATIONS
EXHIBIT 56 SEMI-SOLID CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 57 SEMI-SOLID CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 58 INCREMENTAL GROWTH BY AGE GROUP 2021 & 2027
EXHIBIT 59 CLINICAL NUTRITION MARKET IN US BY AGE GROUP 2021-2027
EXHIBIT 60 CLINICAL NUTRITION MARKET IN US BY AGE GROUP: OVERVIEW
EXHIBIT 61 CLINICAL NUTRITION MARKET IN US BY AGE GROUP: INCREMENTAL GROWTH
EXHIBIT 62 CLINICAL NUTRITION MARKET IN US BY AGE GROUP: ABSOLUTE GROWTH
EXHIBIT 63 US TEEN DEMOGRAPHICS IN 2021
EXHIBIT 64 OBESITY PREVALENCE AMONG US CHILDREN & TEENAGE FROM 1970 TO 2022
EXHIBIT 65 CHILD & TEENAGER CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 66 CHILD & TEENAGER CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 67 ADULT CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 68 ADULT CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 69 US: INSTITUTIONAL MANAGEMENT SUB-DOMAIN SCORE FOR MATERNITY PRACTICES IN INFANT NUTRITION AND CARE BY STATE 2018
EXHIBIT 70 INFANT & TODDLER CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 71 INFANT & TODDLER CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 72 CHILD & TEENAGER CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 73 OBESITY PREVALENCE AMONG GERIATRIC POPULATION IN US IN 2010 (%)
EXHIBIT 74 GERIATRIC CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 75 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 76 CLINICAL NUTRITION MARKET IN US BY APPLICATION 2021-2027
EXHIBIT 77 CLINICAL NUTRITION MARKET IN US BY APPLICATION OVERVIEW
EXHIBIT 78 CLINICAL NUTRITION MARKET IN US BY APPLICATION: INCREMENTAL GROWTH
EXHIBIT 79 CLINICAL NUTRITION MARKET IN US BY APPLICATION: ABSOLUTE GROWTH
EXHIBIT 80 US HUNGER STATISTICS 2020
EXHIBIT 81 CLINICAL NUTRITION MARKET IN US BY MALNUTRITION: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 82 TOP TEN HUNGRIEST STATES IN US
EXHIBIT 83 MALNUTRITION CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 84 SOME COMMON METABOLIC DISORDERS
EXHIBIT 85 METABOLIC DISORDERS CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 86 METABOLIC DISORDERS CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 87 CLINICAL NUTRITION MARKET IN US BY GASTROINTESTINAL DISORDER: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 88 CLINICAL NUTRITION MARKET IN US BY GASTROINTESTINAL DISEASES 2021–2027 ($ BILLION)
EXHIBIT 89 NEW CANCER CASES: FACTS & STATISTICS IN US (2020)
EXHIBIT 90 STRUCTURE OF ESPEN PRACTICAL GUIDELINES: CLINICAL NUTRITION IN CANCER
EXHIBIT 91 CLINICAL NUTRITION MARKET IN US BY CANCER: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 92 CLINICAL NUTRITION MARKET IN US BY CANCER 2021–2027 ($ BILLION)
EXHIBIT 93 US CARDIOVASCULAR DISEASES RISK FACTOR INCREASE BETWEEN 2025 AND 2060
EXHIBIT 94 OTHER APPLICATION CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 95 OTHERS APPLICATION CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 96 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027
EXHIBIT 97 CLINICAL NUTRITION MARKET IN US BY DISTRIBUTION CHANNELS 2021-2027
EXHIBIT 98 CLINICAL NUTRITION MARKET IN US BY DISTRIBUTION CHANNELS: OVERVIEW
EXHIBIT 99 CLINICAL NUTRITION MARKET IN US BY DISTRIBUTION CHANNELS: INCREMENTAL GROWTH
EXHIBIT 100 CLINICAL NUTRITION MARKET IN US BY DISTRIBUTION CHANNELS: ABSOLUTE GROWTH
EXHIBIT 101 INSTITUTIONAL SALES CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 102 INSTITUTIONAL SALES CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 103 SUPERMARKET & HYPERMARKET CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 104 SUPERMARKET & HYPERMARKET CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 105 US E-COMMERCE SALES ($ BILLION)
EXHIBIT 106 ONLINE CHANNELS CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 107 ONLINE DISTRIBUTION CHANNELS CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 108 PHARMACIES & DRUG STORES CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 109 PHARMACIES AND DRUG STORES CLINICAL NUTRITION MARKET IN US. 2021–2027 ($ BILLION)
EXHIBIT 110 SPECIALTY STORES CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 111 SPECIALTY STORES CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 112 CLINICAL NUTRITION MARKET IN US BY OTHER DISTRIBUTION CHANNEL: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 113 OTHERS DISTRIBUTION CHANNELS CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 114 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 115 CLINICAL NUTRITION MARKET IN US BY END-USER 2021-2027
EXHIBIT 116 CLINICAL NUTRITION MARKET IN US BY END-USER: OVERVIEW
EXHIBIT 117 CLINICAL NUTRITION MARKET IN US BY END-USER: INCREMENTAL GROWTH
EXHIBIT 118 CLINICAL NUTRITION MARKET IN US BY END-USER: ABSOLUTE GROWTH
EXHIBIT 119 HOSPITALS STAY IN US & MALNUTRITION 2018
EXHIBIT 120 HOSPITALS CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 121 HOSPITALS CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 122 INDIVIDUAL CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 123 INDIVIDUAL CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 124 HOMECARE CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 125 HOMECARE CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 126 LONG-TERM CARE CENTERS CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 127 LONG-TERM CARE CENTERS CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 128 VENDORS OFFERING CLINICAL NUTRITION MARKET: CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 129 VENDORS OFFERING CLINICAL NUTRITION: MARKET DOMINANCE ANALYSIS
EXHIBIT 130 ABBOTT: ANNUAL REVENUE 2019-2021 ($ MILLION)
EXHIBIT 131 B. BRAUN MELSUNGEN REVENUE 2019-2021 ($ MILLION)
EXHIBIT 132 BAXTER: ANNUAL REVENUE 2019-2021 ($ MILLION)
EXHIBIT 133 BAXTER: ANNUAL REVENUE BY CLINICAL NUTRITION 2019-2021 ($ MILLION)
EXHIBIT 134 DANONE: REVENUE BY BUSINESS SEGMENT IN 2021 (%)
EXHIBIT 135 DANONE: REVENUE BY GEOGRAPHY IN 2021 (%)
EXHIBIT 136 DANONE: ANNUAL REVENUE 2019-2021 ($ BILLION)
EXHIBIT 137 FRESENIUS KABI: REVENUE 2019-2021 ($ BILLION)
EXHIBIT 138 FRESENIUS KABI SALES BY GEOGRAPHY 2021 (%)
EXHIBIT 139 FRESENIUS KABI SALES BY SEGMENT 2021 (%)
EXHIBIT 140 PERRIGO COMPANY. ANNUAL REVENUE 2019-2021 ($ MILLION)
EXHIBIT 141 PERRIGO COMPANY REVENUE BY NUTRITION SEGMENT 2021 ($ MILLION)
EXHIBIT 142 RECKITT BENCKISER GROUP ANNUAL REVENUE 2019-2021 ($ BILLION)
EXHIBIT 143 RECKITT BENCKISER GROUP REVENUE BY NUTRITION BUSINESS SEGMENT 2019-2021 ($ MILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 ENTERAL FEEDING BARRIERS IN PEDIATRIC ICU
TABLE 4 SOME OF ORAL NUTRITION SOLUTIONS IN US CLINICAL NUTRITION MARKET
TABLE 5 ORAL CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION 2021−2027 ($ BILLION)
TABLE 6 ORAL CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION 2021−2027 (%)
TABLE 7 ENTERAL US CLINICAL NUTRITION MARKET BY AGE GROUP 2021−2027 ($ BILLION)
TABLE 8 ENTERAL CLINICAL NUTRITIONAL MARKET BY AGE GROUP 2021−2027 (%)
TABLE 9 PARENTERAL CLINICAL NUTRITION MARKET BY AGE GROUP 2021−2027 ($ BILLION)
TABLE 10 PARENTERAL CLINICAL NUTRITION MARKET BY AGE GROUP 2021−2027 (%)
TABLE 11 POWDER FORM LEADING CLINICAL NUTRITION PRODUCTS
TABLE 12 FACTS ABOUT NUTRITION-RELATED HEALTH CONDITIONS IN US ADULT POPULATION -2020
TABLE 13 BREASTFEEDING RATE IN US IN 2020
TABLE 14 ABBOTT: MAJOR PRODUCT OFFERINGS
TABLE 15 B. BRAUN MELSUNGEN AG: MAJOR PRODUCT OFFERINGS
TABLE 16 BAXTER: MAJOR PRODUCT OFFERINGS
TABLE 17 DANONE: MAJOR PRODUCT OFFERINGS
TABLE 18 FRESENIUS KABI: MAJOR PRODUCT OFFERINGS
TABLE 19 NESTLE: MAJOR PRODUCT OFFERINGS
TABLE 20 PERRIGO COMPANY: MAJOR PRODUCT OFFERINGS
TABLE 21 RECKITT BENCKISER GROUP: MAJOR PRODUCT OFFERINGS
TABLE 22 ADM: MAJOR PRODUCT OFFERINGS
TABLE 23 AJINOMOTO CO: MAJOR PRODUCT OFFERINGS
TABLE 24 BASF SE: MAJOR PRODUCT OFFERINGS
TABLE 25 DSM: MAJOR PRODUCT OFFERINGS
TABLE 26 ENVARA HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 27 GLANBIA (GLANBIA NUTRITIONALS): MAJOR PRODUCT OFFERINGS
TABLE 28 HERO NUTRITIONALS: MAJOR PRODUCT OFFERINGS
TABLE 29 HUM NUTRITION: MAJOR PRODUCT OFFERINGS
TABLE 30 KENDAL NUTRICARE: MAJOR PRODUCT OFFERINGS
TABLE 31 LONZA: MAJOR PRODUCT OFFERINGS
TABLE 32 LACTALIS NUTRITION SANTÉ: MAJOR PRODUCT OFFERINGS
TABLE 33 MEND: MAJOR PRODUCT OFFERINGS
TABLE 34 MEDIFOOD INTERNATIONAL SA: MAJOR PRODUCT OFFERINGS
TABLE 35 PRIMUS PHARMACEUTICALS: MAJOR PRODUCT OFFERINGS
TABLE 36 STERNLIFE GMBH & CO. KG: MAJOR PRODUCT OFFERINGS
TABLE 37 THE CRAFT HEINZ COMPANY: MAJOR PRODUCT OFFERINGS
TABLE 38 VIVANTE HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 39 CLINICAL NUTRITION MARKET IN US BY PRODUCT 2021−2027 ($ BILLION)
TABLE 40 CLINICAL NUTRITION MARKET IN US BY PRODUCT 2021−2027 (%)
TABLE 41 CLINICAL NUTRITION MARKET IN US BY ROUTE OF ADMINISTRATION 2021−2027 ($ BILLION)
TABLE 42 CLINICAL NUTRITION MARKET IN US BY ROUTE OF ADMINISTRATION 2021−2027 (%)
TABLE 43 CLINICAL NUTRITION MARKET IN US BY AGE GROUP 2021−2027 ($ BILLION)
TABLE 44 CLINICAL NUTRITION MARKET IN US BY AGE GROUP 2021-2027 (%)
TABLE 45 CLINICAL NUTRITION MARKET IN US BY APPLICATION 2021−2027 ($ BILLION)
TABLE 46 CLINICAL NUTRITION MARKET IN US BY APPLICATION 2021−2027 (%)
TABLE 47 CLINICAL NUTRITION MARKET IN US BY DISTRIBUTION CHANNELS 2021−2027 ($ BILLION)
TABLE 48 CLINICAL NUTRITION MARKET IN US BY DISTRIBUTION CHANNELS 2021−2027 (%)
TABLE 49 CLINICAL NUTRITION MARKET IN US BY END-USERS 2021−2027 ($ BILLION)
TABLE 50 CLINICAL NUTRITION MARKET IN US BY END-USERS 2021−2027 (%)
TABLE 51 ORAL CLINICAL NUTRITION MARKET IN US BY AGE GROUP 2021−2027 ($ BILLION)
TABLE 52 ORAL CLINICAL NUTRITION MARKET IN US BY AGE GROUP 2021-2027 (%)
TABLE 53 ENTERAL CLINICAL NUTRITION MARKET IN US BY AGE GROUP 2021−2027 ($ BILLION)
TABLE 54 ENTERAL CLINICAL NUTRITION MARKET IN US BY AGE GROUP 2021-2027 (%)
TABLE 55 PARENTERAL CLINICAL NUTRITION MARKET IN US BY AGE GROUP 2021−2027 ($ BILLION)
TABLE 56 PARENTERAL CLINICAL NUTRITION MARKET IN US BY AGE GROUP 2021-2027 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
